Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID‐19 vaccinations, Western Australia, 22 February to 30 June 2021
Internal Medicine Journal · 2023
DOI: 10.1111/imj.16001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2023. Verfasst von Alexander Shivarev und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Anaphylaxis, COVID-19, COVID-19 Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Within the first 4 months of the Western Australian COVID‐19 immunisation programme, 49 suspected anaphylaxis cases were reported to the vaccine safety surveillance system. Twelve reports met Brighton Collaboration case definition, corresponding to rates of 15.9 and 17.7 per million doses of Vaxzevria and Comirnaty administered respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
- Metropolitan Communicable Disease Control, North Metropolitan Health Service, Perth, Western Australia, Australia.
- Western Australian Vaccine Safety Surveillance and Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia.
- Discipline of Paediatrics, Medical School, The University of Western Australia, Perth, Western Australia, Australia.
- Department of General Paediatrics and Immunology, Perth Children's Hospital, Perth, Western Australia, Australia.
- Department of Health, Communicable Disease Control Directorate, Perth, Western Australia, Australia.
ORCID-Profile: Alexander Shivarev, Andrew McLean-Tooke
Zitieren
APA
Shivarev, A., Phillips, A., Brophy-Williams, S., Ford, T., Richmond, P., Effler, P., & McLean-Tooke, A. (2023). Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID‐19 vaccinations, Western Australia, 22 February to 30 June 2021. Internal Medicine Journal. https://doi.org/10.1111/imj.16001
Vancouver
Shivarev A, Phillips A, Brophy-Williams S, Ford T, Richmond P, Effler P, et al. Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID‐19 vaccinations, Western Australia, 22 February to 30 June 2021. Internal Medicine Journal. 2023. doi:10.1111/imj.16001
BibTeX
@article{Shivarev2023,
author = {Shivarev, Alexander and Phillips, Anastasia and Brophy-Williams, Sam and Ford, Tim and Richmond, Peter and Effler, Paul and McLean-Tooke, Andrew},
title = {Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID‐19 vaccinations, Western Australia, 22 February to 30 June 2021},
journal = {Internal Medicine Journal},
year = {2023},
doi = {10.1111/imj.16001}
}
EUVIMED